WO2017173436A1 - Regulatory device and associated method - Google Patents

Regulatory device and associated method Download PDF

Info

Publication number
WO2017173436A1
WO2017173436A1 PCT/US2017/025702 US2017025702W WO2017173436A1 WO 2017173436 A1 WO2017173436 A1 WO 2017173436A1 US 2017025702 W US2017025702 W US 2017025702W WO 2017173436 A1 WO2017173436 A1 WO 2017173436A1
Authority
WO
WIPO (PCT)
Prior art keywords
user
stimulation
physical parameters
regulatory device
detecting
Prior art date
Application number
PCT/US2017/025702
Other languages
French (fr)
Inventor
Greg J. SIEGLE
David Mayer Lowell RABIN
Original Assignee
University Of Pittsburgh-Of The Commonwealth System Of Higher Education
Upmc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Pittsburgh-Of The Commonwealth System Of Higher Education, Upmc filed Critical University Of Pittsburgh-Of The Commonwealth System Of Higher Education
Priority to AU2017240259A priority Critical patent/AU2017240259A1/en
Priority to US16/088,608 priority patent/US11660442B2/en
Priority to CA3019351A priority patent/CA3019351C/en
Priority to EP17776899.1A priority patent/EP3436135B1/en
Priority to JP2019502540A priority patent/JP6952762B2/en
Priority to KR1020187031837A priority patent/KR102452785B1/en
Priority to CN201780029173.8A priority patent/CN109152917B/en
Priority to IL262065A priority patent/IL262065B2/en
Publication of WO2017173436A1 publication Critical patent/WO2017173436A1/en
Priority to US16/596,351 priority patent/US20200061377A1/en
Priority to AU2022221421A priority patent/AU2022221421A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/0404Electrodes for external use
    • A61N1/0408Use-related aspects
    • A61N1/0452Specially adapted for transcutaneous muscle stimulation [TMS]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0048Detecting, measuring or recording by applying mechanical forces or stimuli
    • A61B5/0051Detecting, measuring or recording by applying mechanical forces or stimuli by applying vibrations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024Detecting, measuring or recording pulse rate or heart rate
    • A61B5/02405Determining heart rate variability
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024Detecting, measuring or recording pulse rate or heart rate
    • A61B5/02416Detecting, measuring or recording pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/053Measuring electrical impedance or conductance of a portion of the body
    • A61B5/0531Measuring skin impedance
    • A61B5/0533Measuring galvanic skin response
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/16Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A61B5/165Evaluating the state of mind, e.g. depression, anxiety
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/44Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441Skin evaluation, e.g. for skin disorder diagnosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M21/02Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis for inducing sleep or relaxation, e.g. by direct nerve stimulation, hypnosis, analgesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/0404Electrodes for external use
    • A61N1/0408Use-related aspects
    • A61N1/0456Specially adapted for transcutaneous electrical nerve stimulation [TENS]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36025External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/3603Control systems
    • A61N1/36031Control systems using physiological parameters for adjustment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/01Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0072Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus with application of electrical currents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/04Heartbeat characteristics, e.g. ECG, blood pressure modulation
    • A61M2230/06Heartbeat rate only

Definitions

  • This application generally relates to devices that can be held against the body or attached to something connected to the body to promote change in at least one of emotional state, arousal state, and cognition.
  • Interventions for stress primarily consist of psychological therapies/techniques and drug/prophylactic therapies.
  • Psychological techniques e.g., as taught in psychotherapy or meditation
  • Literature suggests such interventions do not work for many people. For example, individuals who tend to ruminate do most poorly in even the best psychological therapies.
  • Drug/prophylactic therapies depend on an agent taken at one time point to have effects much later when they are needed. These treatments have many side effects and are often addictive.
  • a common observation is that most psychiatric medications, in tolerable doses, are not strong enough to prevent or even improve in-the-moment reactivity to stressors.
  • the invention regards regulation of physiological states using cutaneous transducers (vibration or electricity) at times of stress or deviation from a target emotion state (e.g., "calm").
  • a target emotion state e.g., "calm”
  • regulatory devices that provide specific types of physiologically reactive stimulation useful for regulating arousal and stress
  • 2) invocation via manual switching or sensors and algorithms to determine its need and 3) individualized calibrations and learning algorithms to determine optimal parameters for sensing and regulating a given person's arousal, stress, or distance from a target physiological state such as calm.
  • technologies regards techniques that associate physiological reactivity profiles with stored idiosyncratic emotion states (e.g., "calm”), yield dynamic quantification of distance from these target states, and provide physiological stimulation that returns users to these target emotion states via closed loop stimulation.
  • stored idiosyncratic emotion states e.g., "calm”
  • a regulatory device touching the skin of a user, or something that is touching the skin or body of the user provides stimulation at frequencies demonstrated in the published literature to change sympathetic and parasympathetic tone.
  • the device can be worn, e.g., on a wrist, the neck, or the sternum, all of which have been demonstrated to yield increases in vagal / parasympathetic tone or sympathetic tone with certain frequencies of cutaneous oscillation.
  • the transducer for cutaneous oscillation is strong enough to produce non- ignorable signals. Electricity and vibration can both serve that function.
  • the invention thus includes software for generating an acoustic signal with specific oscillatory characteristics, a transceiver (e.g., Bluetooth receiver) for acoustic signals generated, by the device wirelessly, an amplifier, and any tactile transducer capable of feeding the amplified acoustic signal to the body in a way that is not ignorable.
  • a transceiver e.g., Bluetooth receiver
  • the mechanisms by which vibration and electrical stimulation can induce changes in stress and parasympathetic tone are well described in the literature.
  • the skin has other receptors that process touch (mechanoreceptors), pain (nociceptors), pleasure (c-tactile fibers) and temperature (thermoreceptors).
  • Information gathered by skin receptors travels to the brain's somatosensory cortex and in parallel, to areas of the brain involved in cognitive processes, motor processes, social processes, and networks more involved in emotional functions, including recognizing and generating emotion (the amygdala, insula, and striatum, for example), and regulating emotion (the prefrontal cortex, for instance).
  • recognizing and generating emotion the amygdala, insula, and striatum, for example
  • regulating emotion the prefrontal cortex, for instance.
  • Emotions can be generated not just from present inputs but from our interpretation of bodily cues (Damasio, 1999, xii, 386 p.) based on previous experiences as well.
  • tactile stimulation could affect brain function.
  • deep tactile stimuli can affect specific nerves directly yielding predictable neural effects.
  • Slow moving touch around the carotid sinus e.g., via "carotid massage” can potentiate vagus nerve function (Ha, et al. , 2015, Am J Emerg Med, 33(7), 963-5, McDonald, et al. , 2014, J Am Geriatr Soc, 62(10), 1988-9, Laine Green and Weaver, 2014, J Clin
  • Manual therapies like massage have implicated varying mechanisms such as release of endocannabinoids (Lindgren, et al. , 2015, BMC Res Notes, 8(504).
  • Different styles of massage to the same area have been found to activate different brain networks (Sliz, et al., 2012, Brain Imaging Behav, 6(1), 77-87) suggesting a more complex picture of the touch-brain relationship.
  • Deep chest pressure (e.g., as used in "hug machines") directly appears to affect baroreceptors (Edelson, et al., 1999, Am J Occup Ther, 53(2), 145-52) yielding decreased blood pressure and feelings of calm.
  • Accupressure which involves deep touch has been conceptualized from a variety of perspectives and also appears to affect peripheral physiology such as heart rate variability (McFadden, et al., 2012, Complement Ther Med, 20(4), 175-82, Huang, et al., 2005, Am J Chin Med, 33(1), 157-64) suggesting potential vagus nerve involvement.
  • this invention relies on beat frequencies in the 0.01-20 Hz range which are well-documented to be psychophysiologically reactive. Slow whole-body vibration, in the 0.01 to 0.3 Hz range, is associated with increased ratings of
  • 0.1 Hz is known as the frequency of cardiac resonance (high-amplitude synchronous oscillations at a single frequency).
  • This cardiac resonance is achieved with generally lower frequency stimulation in tall people/men and generally higher frequency stimulation in smaller people/women (Vaschillo, et al., 2006, Appl Psychophysiol Biofeedback, 31 (2), 129-42).
  • any source of rhythmic stimulation that affects the cardiovascular system should produce the same effect (achieving cardiac resonance of 0.1 Hz).
  • rhythmic muscle tension at 0.1 Hz has been found to increase high frequency heart rate variability (Lehrer, et al. , 2009, Biol Psychol, 81 (1 ), 24-30, Vaschillo, et al., 201 1 , Psychophysiology, 48(7), 927-36) as has rhythmic visual stimulation at 0.1 Hz (Vaschillo, et al. , 2008, Psychophysiology, 45(5), 847-58). Wrist- worn vibratory cues in this range have been shown to affect hemodynamics following stressful tasks (Nogawa, et al. , 2007, Conf Proc I EEE Eng Med Biol Soc, 2007(5323-5).
  • Vibration in the 6-10Hz range appears to decrease parasympathetic tone, as measured by high frequency heart rate variability (Jiao, et al., 2004, Int Arch Occup Environ Health, 77(3), 205-12, Bjor, et al., 2007, Int Arch Occup Environ Health, 81 (2), 193-9) and is specifically associated in increased low-to-high frequency heart rate variability rations, potentially suggestive of increased sympathetic tone (Watanabe and Ujike, 2012, Health, 4(11), 1029-1035). Increasingly peripheral stimulation at 10hz is being used to modulate activity in the vagus nerve, which governs heart-rate variability, and thus
  • This invention also relies on base frequencies in the 20-300 Hz range which are also well-documented to be physiologically reactive.
  • a large literature devoted to whole- body vibration has primarily examined the 20-36 Hz range, which is generally associated with increased heart rates (e.g. , Gojanovic, et al., 2014, Physiol Res, 63(6), 779-92, Cochrane, et al., 2008, Arch Phys Med Rehabil, 89(5), 815-21 ).
  • 25Hz whole-body vibration is associated with decreased heart rate and baroreceptor activity consistent with parasympathetic response, particularly in obese people (Dipla, et al.
  • Vibrator massage is associated with both increased heart rate but also increased theta and alpha EEG associated with relaxation (Diego, et al. , 2004, Int J Neurosci, 1 14(1), 31-44).
  • Electroacupuncture produces the sensation of rapid vibration; stimulation at 100 Hz is associated with increased subsequent high frequency heart rate variability (Hideaki, et al., 2015, Acupunct Med, 33(6), 451-6) though TENS unit stimulation at 100 Hz has been observed to produce decreased high frequency heart rate variability (Stein, et al. , 201 1 , Auton Neurosci, 165(2), 205-8). Facial vibration at 89 Hz has specifically been associated with increased parasympathetic tone (Hiraba, et al., 2014, Biomed Res Int, 2014(910812).
  • the regulatory device combines low and high frequencies described as physiologically reactive in the literature to yield unique superadditive sensations.
  • complex musical and complex vibroacoustic stimuli have been shown to modulate a variety of neural responses associated with vagal tone (Bergstrom-lsacsson, et al. , 2014, Res Dev Disabil, 35(6), 1281-91).
  • Vibroacoustic stimulation has been shown to affect electroencephalographic recordings as well as positive mood (Sandler, et al., 2016, Brain Topogr, 29(4), 524-38).
  • intervention is invoked by detecting a predetermined condition, such as a manual switching on the regulatory device or the detection by the regulatory device of a predetermined condition in the form of physiological changes associated with an increase or decrease in arousal or stress.
  • Manual switching is done by invoking software, e.g., on a smartphone, or via a switch on the device.
  • Many physiological parameters can be used to detect emotion and arousal states such as stress or fatigue, including but not limited to changes in vocal tone, galvanic skin response, and heart rate variability, pupil dilation, and gamma band EEG.
  • the invention thus includes software for establishing an individual's resting, stressed, fatigued, or user-defined target profiles on available physiological measurements, and for comparing, in real time, measurements of derived parameters to these states, and inferring the extent to which a current state appears similar to those stored states (e.g., stress or fatigue) with respect to individually titrated parameters.
  • the invention includes calibration procedures to assess subjective and, when possible, physiological reactivity to different combinations of frequencies to allow best-suited regulatory stimulation.
  • an individual's physiological features associated with potentially user-defined emotion and arousal states along with stimulation parameters that optimally restore those states can be stored in a library for later recall by that or another individual. For example, if an individual is having a particularly good day, physiology associated with that state can be stored, and stimulation parameters that optimally maintain that state or move from stressed or fatigued states towards that state can be stored in the library for later recall.
  • FIG 1 Example implemented regulatory device with Vibratory Transducer.
  • FIG 2 Example implemented regulatory device with Electrical Transducer
  • FIGS 3A and 3B Data showing average valence and arousal ratings associated with multiple types of stimulation in 38 volunteers experiencing chest and wrist stimulation using combined oscillations, indicated as main frequency, modulating frequency.
  • FIG 4 Example of user interface of software for detection of physiological stress for use with any commercial hardware that records skin conductance and pulse plethysmograph, e.g., iOS or Bitalino, the data from which can be read, e.g. , as a serial stream.
  • skin conductance and pulse plethysmograph e.g., iOS or Bitalino
  • FIG 5 Example of user interface of software for detection of vocal stress.
  • FIG 6 Data showing clear physiological changes associated with stress onset that can easily be classified by looking at slopes of change.
  • FIGS 7A, 7B, 7C, and 7D Data showing individual differences in which patterns are most calming and arousing for different individuals, supporting the utility of individual customization.
  • the associated boxes and arrows represent functions of the process according to the present invention, which may be implemented as electrical circuits and associated wires or via wireless protocols such as Bluetooth, which transport acoustic signals.
  • one or more associated arrows may represent communication (e.g. , data flow) between software routines, particularly when the present method or apparatus of the present invention is a digital process. Regulatory device
  • the regulatory device 4 depicted generally in FIG 1 includes a rechargeable 6000mAh Li-Ion Battery Pack 8, 12V DC, With Charger, a DC 10- 22V AC 10-16V 25W 4 Ohm Audio Speaker HI FI Digital Amplifier Board 12 w/ SD card input, a tactile transducer 16 which, for instance, is a Bass Shaker 8 Ohm which can be extended from the interior via wires from the amplifier board 12, a 3D printed casing 20 with beveled opening for wires from the transducer 16, an SD Card 24 containing pre-loaded stimulation waveforms including: 20, 33, 40, 89, 100, 200 Hz modulated by 0, 0.1 , 1 , and 4 Hz, Buttons 28 for manually scrolling through pre-loaded waveforms and for providing other inputs to the regulatory device 4, a Bluetooth receiver 32, an LED 36 showing whether the regulatory device 4 in in an ON state, a Switch 40 to turn the regulatory device 4 to the ON state, a Dial 44 to manually modulate waveform intensity, and a processor apparatus 46 having a
  • the expression "a number of” and variations thereof shall refer to any non-zero quantity, including a quantity of one.
  • the Bluetooth receiver 32 is most advantageous when the device that generates the oscillation signals is remote from the casing 20, such as a smart phone or other computerized device, which communicates via its own Bluetooth transmitter the oscillation signals to the Bluetooth receive 32.
  • the routines 56 can be in the form of a non-transitory storage medium which, when executed on computerized device, causes the computerized device to perform operations such as the operations noted herein.
  • the regulatory software routines 56 emit a combination of sine wave oscillations of different frequencies to result in a beat frequency that is output to the user.
  • the combination of oscillations comprise a main oscillation in the range of about 20-300 Hz and at least one modulation oscillation in the range of about 0.01-10 Hz yielding a beat output that provides to the user a feeling of slow waves of stimulation at a frequency determined to be arousing or calming via the calibration software.
  • any of multiple base waveform types described as being physiologically active in the literature can generate as a main oscillation any of 20, 33, 40, 89, 100, and 200 Hz
  • modulatory frequencies also referenced in the literature the implemented device in Fig 1 can also generate modulation oscillations of 0.1 , 1 , and 4 Hz), any of which can be selected via the buttons 28 on the device in Fig 1 or an external software program that may be executed on, for instance, a smart phone or any other remote computerized device.
  • the Bluetooth receiver 32 pairs with whatever device generates the chosen waveforms via external software that runs on a computer or smartphone.
  • the battery 8 is rechargeable and is sufficient to power the amplifier 12 and transducer 16, e.g., 6000mAh Li-Ion battery pack.
  • the amplifier 12 boosts the oscillation signals to a level that is useable by the transducer 16.
  • the amplifier 12 converts the oscillation signals to a level that a 20W 8 ohm tactile transducer can faithfully reproduce.
  • the amplifier converts audio signals to pulse-width-modulated versions (250 ⁇ 3 pulses separated by 5 I3 gaps) to prevent skin heating, using standard algorithms, and amplifies them to a physiologically detectable threshold (approx. 2 mAmps) and includes optical isolation and voltage limitation for safety.
  • the vibratory tactile transducer 16 is designed to be used over any area of the body, which might respond to oscillations produced by the software.
  • the tactile transducer 16 may also deliver whole-body vibrations by being attached to a chair or bed.
  • FIG 1 illustrates one embodiment of one vibratory transducer.
  • the vibratory transducer 16 is to be used on the neck, sternum, advantageous when the device that generates the oscillation signals is remote from the casing 20, such as a smart phone or other computerized device, which communicates via its own Bluetooth transmitter the oscillation signals to the Bluetooth receive 32.
  • the routines 56 can be in the form of a non-transitory storage medium which, when executed on computerized device, causes the computerized device to perform operations such as the operations noted herein.
  • the regulatory software routines 56 emit a combination of sine wave oscillations of different frequencies to result in a beat frequency that is output to the user.
  • the combination of oscillations comprise a main oscillation in the range of about 20-300 Hz and at least one modulation oscillation in the range of about 0.01-10 Hz yielding a beat output that provides to the user a feeling of slow waves of stimulation at a frequency determined to be arousing or calming via the calibration software.
  • any of multiple base waveform types described as being physiologically active in the literature can generate as a main oscillation any of 20, 33, 40, 89, 100, and 200 Hz
  • modulatory frequencies also referenced in the literature the implemented device in Fig 1 can also generate modulation oscillations of 0.1 , 1 , and 4 Hz), any of which can be selected via the buttons 28 on the device in Fig 1 or an external software program that may be executed on, for instance, a smart phone or any other remote computerized device.
  • the Bluetooth receiver 32 pairs with whatever device generates the chosen waveforms via external software that runs on a computer or smartphone.
  • the battery 8 is rechargeable and is sufficient to power the amplifier 12 and transducer 16, e.g., 6000mAh Li-Ion battery pack.
  • the amplifier 12 boosts the oscillation signals to a level that is useable by the transducer 16.
  • the amplifier 12 converts the oscillation signals to a level that a 20W 8 ohm tactile transducer can faithfully reproduce.
  • the amplifier converts audio signals to pulse-width-modulated versions (250 ⁇ pulses separated by 5 ⁇ gaps) to prevent skin heating, using standard algorithms, and amplifies them to a physiologically detectable threshold (approx. 2 mAmps) and includes optical isolation and voltage limitation for safety.
  • the vibratory tactile transducer 16 is designed to be used over any area of the body, which might respond to oscillations produced by the software.
  • the tactile transducer 16 may also deliver whole-body vibrations by being attached to a chair or bed.
  • FIG 1 illustrates one embodiment of one vibratory transducer.
  • the vibratory transducer 16 is to be used on the neck, sternum, wrist or another user-determined position and is described herein as being a device that can be used, for instance, at will by resting a body part (e.g. , neck when lying down or wrist when in a chair) on the device or, for instance, by holding it against the body (e.g. , sternum).
  • the tactile transducer 16 is capable of generating low frequency oscillations (to 20 Hz) with sufficient displacement to be not-easily-ignored, and is covered by a sleeve that can be removed and cleaned easily and which provides insulation from the bare metal of the transducer (e.g. , fleece).
  • the regulatory device 104 depicted generally in FIG 2 is similar to the regulatory device 4, except that the regulatory device 104 includes an electrical transducer.
  • the regulatory device 104 includes a 9V alkaline battery 108, amplifier 112, and an electrical transducer 116 which, for instance, is a pair of adhesive electrodes 160 and 164 which can be extended from the interior via wires from the amplifier board 112, a 3D printed casing 120 with beveled opening for wires from the transducer 116, an SD Card 124 containing pre-loaded stimulation waveforms including: 20, 33, 40, 89, 100, 200 Hz modulated by 0, 0.1 , 1 , and 4 Hz, Buttons 128 for manually scrolling through preloaded waveforms and for providing other inputs to the regulatory device 104, a
  • the electrical transducer regulatory device 104 is illustrated as being a wearable device and is to be worn on the wrist of the user. It consists of two electrodes 160 and 164 that allow the pulse-width modulated signal from the amplifier to pass from one electrode to the other in the form of a voltage between the electrodes 160 and 164 applied to the skin of the user.
  • FIG 2 illustrates an exemplary embodiment of the electrical transducer regulatory device 104 for communications of oscillations to the skin of the user.
  • the physiological detection suite involves using custom and commercial software and hardware to acquire physiological parameters and analyzing them in real time to detect the onset of individualized signatures of stress, fatigue, or other (e.g. , user specified) emotion or arousal states.
  • FIG 4 shows an example of implemented software for detection of physiological profiles associated with an emotion state and generation of reactive stimulation.
  • FIG 4 depicts a user interface, illustrated based on a screen capture of the software, wherein the user has selected a threshold of three, as is indicated by the "THRESHOLD" indicator, and which is reflected by the dashed line in the bar graph of FIG 4.
  • An exemplary stress level pattern is depicted at the top of FIG 4, and the bar indicator in the bar graph demonstrates that the threshold has not been reached.
  • FIG 4 further depicts the user-selectable option to have either a tactile output in the form of a tactile-vibration/electrical stimulation or an audible output in the form of a chime when the user is determined to be in a stressed state.
  • a user can manually enter an input using the buttons to trigger the outputting of the therapeutic stimulation.
  • the user can select "NONE", which is selected in FIG 4.
  • the event of the detected state of the user in a being stress (or other user selected emotion/arousal) condition with "Vibration" selected, will automatically result in outputting of the associated calibrated therapeutic stimulation.
  • software for detection of physiological states takes in pulse plethysmograph and galvanic skin response (GSR) inputs, sampled at 1000Hz, from existing hardware (e.g., Bitalino, PC) implemented as generic serial streams.
  • GSR galvanic skin response
  • the pulse plethysmograph detects a heartbeat signal that is representative of the heartbeat of the user.
  • GSR data are preprocessed via spike removal and smoothing (4 second kernel) to yield a smooth running estimate of GSR which is associated with sympathetic nervous system reactivity and stress.
  • Plethysmograph data are preprocessed via spike removal and peak detection to yield heartbeats which are converted to an inter-beat interval series.
  • the inter-beat series includes a time duration between each successive beat in the detected heartbeat signal.
  • the inter-beat interval series is subjected to calculation of heart rate (# beats per second).
  • the inter-beat interval series for 30 seconds is subjected to continuous Morlet waveform transform to yield a running estimate of power in the high frequency heart rate variability (HF-HRV) band (0.18-0.4 Hz), which is associated with parasympathetic nervous system activity and emotion regulation capability, and which can be referred to as an emotional regulation parameter or value.
  • HF-HRV high frequency heart rate variability
  • spectra! analysis techniques such as Fourier transformation and the like can be employed without departing from the spirit of the disclosed and claimed concept.
  • One aspect of the algorithm for detection of physiological stress includes quantifying change or slope over a period of time, i.e., 100ms to 30 seconds, in physiological parameters to detect state onset.
  • the algorithm for detecting physiological stress is initially seeded for stress detection as reflecting increasing detected current physical parameters such as GSR or heart rate without a corresponding or subsequent change in HF-HRV, i.e.:
  • Another aspect of the algorithms includes a calibration operation using software that guides the user to experience resting, stressed, fatigued or other user-specified states, and which includes brief exposure to a stress induction known to provoke increases in sympathetic tone and decreases in parasympathetic tone (e.g., paced serial attention task), to yield an individually calibrated profile for these states (e.g., "stress profile").
  • a number of calibration physical parameters of the user such as heart rate signal, GSR signal, and other such parameters, may be detected and stored in the storage 52.
  • the software that performs the guiding can be executed on the regulatory device or can be deployed on a smart phone or other computerized device remote from the regulatory device.
  • Another aspect of the algorithms includes machine learning to derive
  • a machine learning algorithm such as a three-layer pattern recognition neural network with 8 input nodes, 4 hidden nodes, and 1 output node is used to estimate how GSR, Heart Rate, HF-HRV, and estimated change in each of these in the previous 5 seconds combine to predict based on the calibration task described in the preceding paragraph. Effectively this algorithm allows a quantized (sigmoid) ridge-regression estimation of parameters for main effects of each of these parameters, and their potential n-way interactions:
  • estimated-stress ⁇ + p-iAGSRs seconds + 2AHeart Rates seconds + 3
  • Another aspect of the algorithms includes real-time comparison of incoming physiological data in the form of current physical parameters of the user to the individualized best-fit profiles to determine when an individual is beginning to look stressed, fatigued, or a critical distance from a user defined state, so as to trigger the delivery of therapeutic stimulation.
  • Stimulation is signaled whenever the stress index is outside 1.5 standard deviations from its mean, which refers to the aforementioned threshold of "3" in FIG 4. Stimulation is signaled at lower and higher stress levels if the threshold is set lower or higher, respectively, than "3".
  • FIG 6 shows that we can derive a classifier that detects the onset of stress during a stressful serial addition task.
  • FIG 5 shows an example of implemented software for detection of vocal stress.
  • One aspect of the vocal stress detection algorithm is that speech is recorded in 5- second segments. These segments are processed to extract common vocal parameters such as speech rate, pitch, mean frequency, frequency of the first fundamental, variance of the first fundamental, etc. using publicly available code. The speech data from any 5- second segment is not saved after parameters are extracted, and thus no lasting voice recordings are made.
  • Another aspect is that a 4-layer pattern-network classifier was trained to recognize the emotion associated with short vocalizations (neutral, calm, happy, sad, fearful, angry, disgusted, surprised) using the "RAVDESS" speech corpus
  • extracted speech parameters are normalized by subtracting the mean of a set of six five-second "neutral" calibration vocalizations and dividing by the standard deviation these vocalizations.
  • Another aspect of the vocal stress detection algorithm begins with a calibration consisting of recording 30 seconds of silence in a specific room.
  • the variance of incoming 5-second vocalizations are, at each iteration, compared to the variance of the "silence" recording.
  • Audio waveforms with variability outside 2 standard deviations (SD) from the silence recording are considered to be vocalizations; otherwise they are considered silence and not categorized.
  • SD standard deviations
  • a second calibration records an individual person, who is the subject of measurement, speaking in a neutral tone for 30 seconds.
  • Another aspect of the algorithm is that when more than a user-selected number of the vocal parameters (the user can select from 2-8 parameters) are outside 2 SD from the mean of neutral vocalizations, and when the person is deemed, via classification based on the RAVDESS corpus classifier, to have a negative tone (fear, sadness, disgust), the software provides user-selected stimulation waveforms to the stimulation generator.
  • This is depicted in the user interface capture from the software that is depicted in FIG 5 wherein the user has selected a threshold of four parameters, as is indicated by the "THRESHOLD" indicator, and which is reflected by the dashed line in the bar graph of FIG 5.
  • FIG 5 further depicts the user-selectable option to have either a tactile output in the form of a vibration or an audible output in the form of a chime when the user is determined to be in a stressed state.
  • a user can manually enter an input using the buttons to trigger the outputting of the therapeutic stimulation.
  • the user can select "NONE", which is selected in FIG 5. In the Vibration condition, and in the event of the detected state of the user being stress or another user-specified condition, this will automatically result in the outputting of the therapeutic stimulation.
  • the stimulation calibration algorithm performs a customization operation that involves presenting individuals with a plurality of customization stimulations in the form of a range of stimulation parameters and allowing them to rate the emotionality and arousal associated with these types of stimulation.
  • the user inputs to the software a number of responses using a single selection on a grid.
  • the number of responses are representative of how the user perceived the customization stimulation on an arousal scale between very calming and very arousing, and are further representative of how the user tolerated the customization stimulation on a valence scale between very negatively and very positively.
  • the software selects stimulation patterns based on these ratings.
  • the pattern which is rated as maximally positive and maximally calming is used as the calming stimulation pattern for that individual in the event of detecting that the individual is experiencing a stress condition.
  • the pattern which is maximally arousing, regardless of its valence, is used as the arousing stimulation pattern for that individual in the event of detecting that the individual is experiencing a fatigue condition.
  • FIGS 7A, 7B, 7C, AND 7D show that there are reliable overall differences in emotion and arousal as a function of oscillation patterns for the vibrating transducer and that there are individual differences in which patterns are most calming and arousing for different individuals.
  • Each data point in such figures is representative of how the user perceived the customization stimulation on an arousal scale between very calming and very arousing, and additionally how the user tolerated the customization stimulation on a valence scale between very negatively and very positively.
  • Physiological parameters in the form of baseline physical parameters associated with named target emotional states can be stored for later recall as targets (triggers stimulation that decreases distance to the state when it is determined that a number of current physical parameters are more than a
  • Another aspect of the invention includes software that allows subjective and physiologically based storage of stimulation parameters that optimally yield approach or departure from target or alarm states.
  • Another aspect of the present invention includes software that allows users to specify potentially new or idiosyncratic target or alarm emotion states for storage in a library which includes associated physiological profiles and stimulation parameters.
  • physiological profiles can be used to gauge distance from normed and idiosyncratically named categories by the cosine of current physiological parameters with those for calibrated states, e.g., yielding a
  • GSRsession mean *(GSR_ calibration state” GSR_caiibration session mean) and deriving the "Closeness" to a state as BGS *CGSR+B H Rv*CHRv+Bvocai Pitch*Cvocai Pitch where associated B weights are derived via neural network classifiers as described herein before.
  • This algorithm provides distance from target states. Before calibration, a priori rules are used to specify output transduction to optimally restore a state via minimizing distance (e.g., Euclidean) of current data from template vectors as described herein before.
  • distance e.g., Euclidean
  • Another aspect of the present invention includes software that allows users to share emotion state names, associated physiological profiles, and stimulation parameters for approaching or avoiding them.
  • a source for generating physiologically reactive oscillation patterns e.g., smartphone
  • the oscillation patterns are frequencies in the range of 20-300 Hz modulated by frequencies from 0.01-10 Hz.
  • the source generates oscillations and transmits them via Bluetooth.
  • Software is used to calibrate and store what vibration patterns maximally yield specific emotional states, including those specified by a user, such as arousal, or positive-affect calm for a given individual, or that individual's state on a given day, to which they would like to return in the future.
  • This software can store what vibration patterns individuals are using and dynamically update its calibration to "learn” if users choose to use patterns not suggested by the previous calibration.
  • a Bluetooth receiver for oscillation patterns generated by the source for oscillation patterns generated by the source.
  • a switch, software control, or physiological/vocal measurement device to determine when the oscillation patterns are delivered.
  • the software computes the magnitude and slope of physiological or vocal measures over a local window (0.5-30 seconds) to determine onsets of emotion state deviations from a neutral state (e.g., stress, fatigue).
  • a neutral state e.g., stress, fatigue
  • the software compares incoming physiological measurements to an individually calibrated profile to determine likelihood of onset of an emotion state and the appropriate reaction.
  • the software has a calibration routine that requires the individual to attain relaxed/neutral, stressed (e.g., via stressful cognitive task), or fatigued states, and record data for profile derivation.
  • the software uses machine learning algorithms (e.g., neural networks) to derive individually calibrated emotion state (e.g., stress) indices from the calibration data used as a training set.
  • machine learning algorithms e.g., neural networks
  • the software stores learned physiological patterns in a library that can be recalled in combination with associated stimulation patterns as described to allow "restoration” of "saved” states.
  • a battery to power the amplifier A battery to power the amplifier.
  • An amplifier that raises the received oscillation patterns to a non-ignorable level.
  • Transducers that provide one of vibratory and electrical stimulation.
  • a sleeve for the vibratory transducer that can be removed and washed.
  • the sleeve may allow the device to be attached to the individual, e.g., via a band or other means for securing the device to the body part without disrupting the transducer's functionality.
  • any reference signs placed between parentheses shall not be construed as limiting the claim.
  • the word “comprising” or “including” does not exclude the presence of elements or steps other than those listed in a claim.
  • several of these means may be embodied by one and the same item of hardware.
  • the word “a” or “an” preceding an element does not exclude the presence of a plurality of such elements.
  • any device claim enumerating several means several of these means may be embodied by one and the same item of hardware.
  • the mere fact that certain elements are recited in mutually different dependent claims does not indicate that these elements cannot be used in combination.

Abstract

A peripheral device for regulating neural correlates of arousal and emotion regulation to be worn or held against the body is disclosed. The device can be triggered by either physiological signs or manual intervention and produces cutaneous signals such as vibration or electricity using novel combinations of physiologically reactive frequencies without effort on the part of the user. One embodiment includes combining sensors that measure changes in physiological signals of stress such as speech rate and pitch, galvanic skin response, or heart rate variability, and, using a machine learning algorithm on personalized data, can determine whether these changes are likely to benefit from regulation. If they are outside an idiosyncratic predetermined range, the device produces stimulation and the person will feel regulated if they are touching / wearing the device, or can choose to use the device if it is not currently being touched or worn.

Description

REGULATORY DEVICE AND ASSOCIATED METHOD
CROSS-REFERENCE TO RELATED APPLICATION
This application claims priority under 35 U.S.C. § 1 19(e) from U.S. provisional patent application serial no. 62/316,695, entitled "Emotion Prosthetics" and filed on April 1 , 2016, the contents of which are incorporated herein by reference.
GOVERNMENT CONTRACT
This invention was made with government support under grant #s MH082998 and MH096334 awarded by the National Institute of Health and under grant # IIP-1449702 awarded by the National Science Foundation. The government has certain rights in the invention.
BACKGROUND OF THE INVENTION
1. Field of the invention
This application generally relates to devices that can be held against the body or attached to something connected to the body to promote change in at least one of emotional state, arousal state, and cognition.
2. Background of the invention
Stress is a specific global impairing problem with no globally effective solution. Approximately a third of the US population describes having more stress than they would like to without effective coping strategies. Chronic unmanaged stress results in time missed from work and impaired productivity, and can lead to debilitating mental and physical illnesses from depression and anxiety to heart disease and dementia.
Interventions for stress primarily consist of psychological therapies/techniques and drug/prophylactic therapies. Psychological techniques (e.g., as taught in psychotherapy or meditation) depend on the user attending to their mental events and emotions, and applying learned techniques in the moment. Literature suggests such interventions do not work for many people. For example, individuals who tend to ruminate do most poorly in even the best psychological therapies. Drug/prophylactic therapies depend on an agent taken at one time point to have effects much later when they are needed. These treatments have many side effects and are often addictive. A common observation is that most psychiatric medications, in tolerable doses, are not strong enough to prevent or even improve in-the-moment reactivity to stressors. What is needed is an intervention that becomes effective at times of stress, intervenes without requiring strong presence of mind on the part of the user, and then stops being active when the stress dissipates. It would be desirable to provide a technology that is applicable to solving problems throughout multiple fields and markets broadly spanning from the medical field (e.g., psychiatry, psychology), to enterprise applications (e.g., HR and training), military applications, consumer models (e.g., stress management), and the entertainment business (e.g., emotionally augmented adaptive virtual reality).
SUMMARY OF THE INVENTION
The invention regards regulation of physiological states using cutaneous transducers (vibration or electricity) at times of stress or deviation from a target emotion state (e.g., "calm"). Thus, included in the invention are 1) regulatory devices that provide specific types of physiologically reactive stimulation useful for regulating arousal and stress, 2) invocation via manual switching or sensors and algorithms to determine its need, and 3) individualized calibrations and learning algorithms to determine optimal parameters for sensing and regulating a given person's arousal, stress, or distance from a target physiological state such as calm. A more general utility of the same
technologies regards techniques that associate physiological reactivity profiles with stored idiosyncratic emotion states (e.g., "calm"), yield dynamic quantification of distance from these target states, and provide physiological stimulation that returns users to these target emotion states via closed loop stimulation.
According to an aspect of the present intervention, a regulatory device touching the skin of a user, or something that is touching the skin or body of the user, provides stimulation at frequencies demonstrated in the published literature to change sympathetic and parasympathetic tone. The device can be worn, e.g., on a wrist, the neck, or the sternum, all of which have been demonstrated to yield increases in vagal / parasympathetic tone or sympathetic tone with certain frequencies of cutaneous oscillation. The transducer for cutaneous oscillation is strong enough to produce non- ignorable signals. Electricity and vibration can both serve that function. The invention thus includes software for generating an acoustic signal with specific oscillatory characteristics, a transceiver (e.g., Bluetooth receiver) for acoustic signals generated, by the device wirelessly, an amplifier, and any tactile transducer capable of feeding the amplified acoustic signal to the body in a way that is not ignorable.
The mechanisms by which vibration and electrical stimulation can induce changes in stress and parasympathetic tone are well described in the literature. The skin has other receptors that process touch (mechanoreceptors), pain (nociceptors), pleasure (c-tactile fibers) and temperature (thermoreceptors). Information gathered by skin receptors travels to the brain's somatosensory cortex and in parallel, to areas of the brain involved in cognitive processes, motor processes, social processes, and networks more involved in emotional functions, including recognizing and generating emotion (the amygdala, insula, and striatum, for example), and regulating emotion (the prefrontal cortex, for instance). (Davidson, 2000, American Psychologist, 55(1196-1214). Emotions can be generated not just from present inputs but from our interpretation of bodily cues (Damasio, 1999, xii, 386 p.) based on previous experiences as well. There are numerous other pathways by which tactile stimulation could affect brain function. For example, deep tactile stimuli can affect specific nerves directly yielding predictable neural effects. Slow moving touch around the carotid sinus (e.g., via "carotid massage") can potentiate vagus nerve function (Ha, et al. , 2015, Am J Emerg Med, 33(7), 963-5, McDonald, et al. , 2014, J Am Geriatr Soc, 62(10), 1988-9, Laine Green and Weaver, 2014, J Clin
Neurosci, 21 (1), 179-80, Cronin and Blake, 201 1 , J Cardiovasc Electrophysiol, 22(5), 600) possibly via direct nerve stimulation or other routes such as stimulation of underlying muscles (Scali, et al., 2013, Spine J, 13(5), 558-63). Manual therapies like massage have implicated varying mechanisms such as release of endocannabinoids (Lindgren, et al. , 2015, BMC Res Notes, 8(504). Different styles of massage to the same area have been found to activate different brain networks (Sliz, et al., 2012, Brain Imaging Behav, 6(1), 77-87) suggesting a more complex picture of the touch-brain relationship. Deep chest pressure (e.g., as used in "hug machines") directly appears to affect baroreceptors (Edelson, et al., 1999, Am J Occup Ther, 53(2), 145-52) yielding decreased blood pressure and feelings of calm. Accupressure, which involves deep touch has been conceptualized from a variety of perspectives and also appears to affect peripheral physiology such as heart rate variability (McFadden, et al., 2012, Complement Ther Med, 20(4), 175-82, Huang, et al., 2005, Am J Chin Med, 33(1), 157-64) suggesting potential vagus nerve involvement. Electrical stimulation, in particular, activates lamina 1 fibers (McMahon and Wall, 1984, Pain, 19(3), 235-47) which convey pain, itch, sensual touch, and temperature through the spinal cord to the primitive brain areas like the amygdala, yielding emotional reactions and, through the thalamus, to the insula to yield awareness of our body's reactions (Craig, 2002, Nat Rev Neurosci, 3(8), 655-66). The insula passes this info on to cortical regions that govern our attention and emotion regulation such as the orbitofrontal cortex (Cavada, et al. , 2000, Cereb Cortex, 10(3), 220-42). Electricity likely produces opioids (Chen, et al. , 1996, J Pharmacol Exp Ther, 277(2), 654-60) along with beta endorphins (Bossut, et al. , 1986, Am J Vet Res, 47(3), 669-76), which affect emotion and pain thresholds (Lundeberg, et al., 1989, Am J Chin Med, 17(3-4), 99-1 10). Electrical stimulation also activates the locus coeruleus (Snow, et al., 1999, Arch Ital Biol, 137(1), 1-28) which is responsible for norepinephrine production which could moderate stress responses.
In particular, this invention relies on beat frequencies in the 0.01-20 Hz range which are well-documented to be psychophysiologically reactive. Slow whole-body vibration, in the 0.01 to 0.3 Hz range, is associated with increased ratings of
pleasantness and increased parasympathetic tone at lower frequencies with increasing predominance of sympathetic tone approaching 0.6 Hz (Uchikune, 2004, Journal of Low Frequency Noise Vibration and Active Control, 23(2), 133-138, Uchikune, 2002, Journal of Low Frequency Noise Vibration and Active Control, 21 (1), 29-36). That said, whole- body stimulation at 1 Hz has been observed to produce increased parasympathetic tone (Takahashi, et al. , 201 1 , J Hum Ergol (Tokyo), 40(1-2), 119-28), with the specific observation of being able to produce vibration-synchronized heart beats. The 0.1 Hz frequency may be particularly useful stimulate at to promote parasympathetic tone, based on biofeedback literature. The highest amplitude of RSA is achieved at 0.1 Hz (6 breaths/minute), because this is the optimal respiratory rate for oxygenation and removal of C02 from the body. As such, 0.1 Hz is known as the frequency of cardiac resonance (high-amplitude synchronous oscillations at a single frequency). This cardiac resonance is achieved with generally lower frequency stimulation in tall people/men and generally higher frequency stimulation in smaller people/women (Vaschillo, et al., 2006, Appl Psychophysiol Biofeedback, 31 (2), 129-42). Thus, it has been suggested that "any source of rhythmic stimulation that affects the cardiovascular system should produce the same effect (achieving cardiac resonance of 0.1 Hz)." (Lehrer and Gevirtz, 2014, Front Psychol, 5(756). Thus, stimulation via rhythmic muscle tension at 0.1 Hz has been found to increase high frequency heart rate variability (Lehrer, et al. , 2009, Biol Psychol, 81 (1 ), 24-30, Vaschillo, et al., 201 1 , Psychophysiology, 48(7), 927-36) as has rhythmic visual stimulation at 0.1 Hz (Vaschillo, et al. , 2008, Psychophysiology, 45(5), 847-58). Wrist- worn vibratory cues in this range have been shown to affect hemodynamics following stressful tasks (Nogawa, et al. , 2007, Conf Proc I EEE Eng Med Biol Soc, 2007(5323-5). Increased heart rates have been found for whole-body vibration at lower frequencies (3- 6Hz) (Maikala, et al., 2006, Int Arch Occup Environ Health, 79(2), 103-14) though individual differences in cardiac effects act these frequencies have been observed (Ullsperger and Seidel, 1980, Eur J Appl Physiol Occup Physiol, 43(3), 183-92).
Vibration in the 6-10Hz range appears to decrease parasympathetic tone, as measured by high frequency heart rate variability (Jiao, et al., 2004, Int Arch Occup Environ Health, 77(3), 205-12, Bjor, et al., 2007, Int Arch Occup Environ Health, 81 (2), 193-9) and is specifically associated in increased low-to-high frequency heart rate variability rations, potentially suggestive of increased sympathetic tone (Watanabe and Ujike, 2012, Health, 4(11), 1029-1035). Increasingly peripheral stimulation at 10hz is being used to modulate activity in the vagus nerve, which governs heart-rate variability, and thus
parasympathetic tone(Ma, et al., 2016, J Neurol Sci, 369(27-35, Bauer, et al., 2016, Brain Stimul, 9(3), 356-63, Jiang, et al., 2016, Neurochem I nt, 97(73-82, He, et al. , 2016, Cardiovasc Ther, 34(3), 167-71).
This invention also relies on base frequencies in the 20-300 Hz range which are also well-documented to be physiologically reactive. A large literature devoted to whole- body vibration has primarily examined the 20-36 Hz range, which is generally associated with increased heart rates (e.g. , Gojanovic, et al., 2014, Physiol Res, 63(6), 779-92, Cochrane, et al., 2008, Arch Phys Med Rehabil, 89(5), 815-21 ). 25Hz whole-body vibration is associated with decreased heart rate and baroreceptor activity consistent with parasympathetic response, particularly in obese people (Dipla, et al. , 2016, Exp Physiol, 101 (6), 717-30), though another study found no change in HRV for 20-36Hz following exercise (Cheng, et al., 2010, J Sports Med Phys Fitness, 50(4), 407-15). That said, electrical stimulation in the 10 Hz range has been found to produce increased HF HRV (Stein, et al. , 201 1 , Auton Neurosci, 165(2), 205-8). Typical personal massage devices operate at about 100 Hz (Prause, et al. , 2012, Sexual and Relationship Therapy, .27(1), pp), with the goal of producing subjective and muscle relaxation. Stimulation at this frequency activates the posterior insula (Coghill, et al. , 1994, J Neurosci, 14(7),
4095-108) which is associated with increased attention to interoception, as promoted in many meditative traditions. Vibrator massage is associated with both increased heart rate but also increased theta and alpha EEG associated with relaxation (Diego, et al. , 2004, Int J Neurosci, 1 14(1), 31-44). Electroacupuncture produces the sensation of rapid vibration; stimulation at 100 Hz is associated with increased subsequent high frequency heart rate variability (Hideaki, et al., 2015, Acupunct Med, 33(6), 451-6) though TENS unit stimulation at 100 Hz has been observed to produce decreased high frequency heart rate variability (Stein, et al. , 201 1 , Auton Neurosci, 165(2), 205-8). Facial vibration at 89 Hz has specifically been associated with increased parasympathetic tone (Hiraba, et al., 2014, Biomed Res Int, 2014(910812).
According to another aspect of the present intervention, the regulatory device combines low and high frequencies described as physiologically reactive in the literature to yield unique superadditive sensations. For example, complex musical and complex vibroacoustic stimuli have been shown to modulate a variety of neural responses associated with vagal tone (Bergstrom-lsacsson, et al. , 2014, Res Dev Disabil, 35(6), 1281-91). Vibroacoustic stimulation has been shown to affect electroencephalographic recordings as well as positive mood (Sandler, et al., 2016, Brain Topogr, 29(4), 524-38).
According to another aspect of the present intervention, use of intervention is invoked by detecting a predetermined condition, such as a manual switching on the regulatory device or the detection by the regulatory device of a predetermined condition in the form of physiological changes associated with an increase or decrease in arousal or stress. Manual switching is done by invoking software, e.g., on a smartphone, or via a switch on the device. Many physiological parameters can be used to detect emotion and arousal states such as stress or fatigue, including but not limited to changes in vocal tone, galvanic skin response, and heart rate variability, pupil dilation, and gamma band EEG. These parameters are interpretable in the presence of a baseline measurement, e.g., of stressed, relaxed, and fatigued states to which similarities on assessed parameters can be inferred. The invention thus includes software for establishing an individual's resting, stressed, fatigued, or user-defined target profiles on available physiological measurements, and for comparing, in real time, measurements of derived parameters to these states, and inferring the extent to which a current state appears similar to those stored states (e.g., stress or fatigue) with respect to individually titrated parameters.
According to another aspect of the invention, individuals differ in the extent to which different frequencies affect physiological reactions. Thus the invention includes calibration procedures to assess subjective and, when possible, physiological reactivity to different combinations of frequencies to allow best-suited regulatory stimulation.
According to another aspect of the invention, an individual's physiological features associated with potentially user-defined emotion and arousal states along with stimulation parameters that optimally restore those states can be stored in a library for later recall by that or another individual. For example, if an individual is having a particularly good day, physiology associated with that state can be stored, and stimulation parameters that optimally maintain that state or move from stressed or fatigued states towards that state can be stored in the library for later recall. BRIEF DESCRIPTION OF THE DRAWINGS
FIG 1 : Example implemented regulatory device with Vibratory Transducer. FIG 2: Example implemented regulatory device with Electrical Transducer FIGS 3A and 3B: Data showing average valence and arousal ratings associated with multiple types of stimulation in 38 volunteers experiencing chest and wrist stimulation using combined oscillations, indicated as main frequency, modulating frequency.
FIG 4: Example of user interface of software for detection of physiological stress for use with any commercial hardware that records skin conductance and pulse plethysmograph, e.g., Arduino or Bitalino, the data from which can be read, e.g. , as a serial stream.
FIG 5: Example of user interface of software for detection of vocal stress.
FIG 6: Data showing clear physiological changes associated with stress onset that can easily be classified by looking at slopes of change.
FIGS 7A, 7B, 7C, and 7D: Data showing individual differences in which patterns are most calming and arousing for different individuals, supporting the utility of individual customization.
DESCRIPTION OF THE PREFERRED EM BODIM ENTS
In the figures to be discussed, the associated boxes and arrows represent functions of the process according to the present invention, which may be implemented as electrical circuits and associated wires or via wireless protocols such as Bluetooth, which transport acoustic signals. Alternatively, one or more associated arrows may represent communication (e.g. , data flow) between software routines, particularly when the present method or apparatus of the present invention is a digital process. Regulatory device
The regulatory device 4 depicted generally in FIG 1 includes a rechargeable 6000mAh Li-Ion Battery Pack 8, 12V DC, With Charger, a DC 10- 22V AC 10-16V 25W 4 Ohm Audio Speaker HI FI Digital Amplifier Board 12 w/ SD card input, a tactile transducer 16 which, for instance, is a Bass Shaker 8 Ohm which can be extended from the interior via wires from the amplifier board 12, a 3D printed casing 20 with beveled opening for wires from the transducer 16, an SD Card 24 containing pre-loaded stimulation waveforms including: 20, 33, 40, 89, 100, 200 Hz modulated by 0, 0.1 , 1 , and 4 Hz, Buttons 28 for manually scrolling through pre-loaded waveforms and for providing other inputs to the regulatory device 4, a Bluetooth receiver 32, an LED 36 showing whether the regulatory device 4 in in an ON state, a Switch 40 to turn the regulatory device 4 to the ON state, a Dial 44 to manually modulate waveform intensity, and a processor apparatus 46 having a processor 48 and a storage 52 having stored therein software in the form of a number of routines 56 that generate a number of oscillation signals. As employed herein, the expression "a number of" and variations thereof shall refer to any non-zero quantity, including a quantity of one. The Bluetooth receiver 32 is most advantageous when the device that generates the oscillation signals is remote from the casing 20, such as a smart phone or other computerized device, which communicates via its own Bluetooth transmitter the oscillation signals to the Bluetooth receive 32. The routines 56 can be in the form of a non-transitory storage medium which, when executed on computerized device, causes the computerized device to perform operations such as the operations noted herein.
The regulatory software routines 56 emit a combination of sine wave oscillations of different frequencies to result in a beat frequency that is output to the user. The combination of oscillations comprise a main oscillation in the range of about 20-300 Hz and at least one modulation oscillation in the range of about 0.01-10 Hz yielding a beat output that provides to the user a feeling of slow waves of stimulation at a frequency determined to be arousing or calming via the calibration software. Any of multiple base waveform types described as being physiologically active in the literature (the implemented device in Fig 1 can generate as a main oscillation any of 20, 33, 40, 89, 100, and 200 Hz) and modulatory frequencies also referenced in the literature (the implemented device in Fig 1 can also generate modulation oscillations of 0.1 , 1 , and 4 Hz), any of which can be selected via the buttons 28 on the device in Fig 1 or an external software program that may be executed on, for instance, a smart phone or any other remote computerized device.
The Bluetooth receiver 32 pairs with whatever device generates the chosen waveforms via external software that runs on a computer or smartphone.
The battery 8 is rechargeable and is sufficient to power the amplifier 12 and transducer 16, e.g., 6000mAh Li-Ion battery pack.
The amplifier 12 boosts the oscillation signals to a level that is useable by the transducer 16. For vibratory stimulation, which is applied as an output to the body of the user, the amplifier 12 converts the oscillation signals to a level that a 20W 8 ohm tactile transducer can faithfully reproduce. For electrical stimulation, which is applied as an output to the user's skin, the amplifier converts audio signals to pulse-width-modulated versions (250 Γ3 pulses separated by 5 I3 gaps) to prevent skin heating, using standard algorithms, and amplifies them to a physiologically detectable threshold (approx. 2 mAmps) and includes optical isolation and voltage limitation for safety.
The vibratory tactile transducer 16 is designed to be used over any area of the body, which might respond to oscillations produced by the software. The tactile transducer 16 may also deliver whole-body vibrations by being attached to a chair or bed. By way of description and not limitation, FIG 1 illustrates one embodiment of one vibratory transducer. The vibratory transducer 16 is to be used on the neck, sternum, advantageous when the device that generates the oscillation signals is remote from the casing 20, such as a smart phone or other computerized device, which communicates via its own Bluetooth transmitter the oscillation signals to the Bluetooth receive 32. The routines 56 can be in the form of a non-transitory storage medium which, when executed on computerized device, causes the computerized device to perform operations such as the operations noted herein.
The regulatory software routines 56 emit a combination of sine wave oscillations of different frequencies to result in a beat frequency that is output to the user. The combination of oscillations comprise a main oscillation in the range of about 20-300 Hz and at least one modulation oscillation in the range of about 0.01-10 Hz yielding a beat output that provides to the user a feeling of slow waves of stimulation at a frequency determined to be arousing or calming via the calibration software. Any of multiple base waveform types described as being physiologically active in the literature (the implemented device in Fig 1 can generate as a main oscillation any of 20, 33, 40, 89, 100, and 200 Hz) and modulatory frequencies also referenced in the literature (the implemented device in Fig 1 can also generate modulation oscillations of 0.1 , 1 , and 4 Hz), any of which can be selected via the buttons 28 on the device in Fig 1 or an external software program that may be executed on, for instance, a smart phone or any other remote computerized device.
The Bluetooth receiver 32 pairs with whatever device generates the chosen waveforms via external software that runs on a computer or smartphone.
The battery 8 is rechargeable and is sufficient to power the amplifier 12 and transducer 16, e.g., 6000mAh Li-Ion battery pack.
The amplifier 12 boosts the oscillation signals to a level that is useable by the transducer 16. For vibratory stimulation, which is applied as an output to the body of the user, the amplifier 12 converts the oscillation signals to a level that a 20W 8 ohm tactile transducer can faithfully reproduce. For electrical stimulation, which is applied as an output to the user's skin, the amplifier converts audio signals to pulse-width-modulated versions (250 με pulses separated by 5 με gaps) to prevent skin heating, using standard algorithms, and amplifies them to a physiologically detectable threshold (approx. 2 mAmps) and includes optical isolation and voltage limitation for safety.
The vibratory tactile transducer 16 is designed to be used over any area of the body, which might respond to oscillations produced by the software. The tactile transducer 16 may also deliver whole-body vibrations by being attached to a chair or bed. By way of description and not limitation, FIG 1 illustrates one embodiment of one vibratory transducer. The vibratory transducer 16 is to be used on the neck, sternum, wrist or another user-determined position and is described herein as being a device that can be used, for instance, at will by resting a body part (e.g. , neck when lying down or wrist when in a chair) on the device or, for instance, by holding it against the body (e.g. , sternum). The tactile transducer 16 is capable of generating low frequency oscillations (to 20 Hz) with sufficient displacement to be not-easily-ignored, and is covered by a sleeve that can be removed and cleaned easily and which provides insulation from the bare metal of the transducer (e.g. , fleece).
Another regulatory device 104 depicted generally in FIG 2 is similar to the regulatory device 4, except that the regulatory device 104 includes an electrical transducer. The regulatory device 104 includes a 9V alkaline battery 108, amplifier 112, and an electrical transducer 116 which, for instance, is a pair of adhesive electrodes 160 and 164 which can be extended from the interior via wires from the amplifier board 112, a 3D printed casing 120 with beveled opening for wires from the transducer 116, an SD Card 124 containing pre-loaded stimulation waveforms including: 20, 33, 40, 89, 100, 200 Hz modulated by 0, 0.1 , 1 , and 4 Hz, Buttons 128 for manually scrolling through preloaded waveforms and for providing other inputs to the regulatory device 104, a
Bluetooth receiver 132, an LED 136 showing whether the regulatory device 104 in in an ON state, a Switch 140 to turn the regulatory device 104 to the ON state, a Dial 144 to manually modulate waveform intensity, and a processor apparatus 146 having a processor 148 and a storage 152 having stored therein software in the form of a number of routines 156 that generate a number of oscillation signals. The electrical transducer regulatory device 104 is illustrated as being a wearable device and is to be worn on the wrist of the user. It consists of two electrodes 160 and 164 that allow the pulse-width modulated signal from the amplifier to pass from one electrode to the other in the form of a voltage between the electrodes 160 and 164 applied to the skin of the user. FIG 2 illustrates an exemplary embodiment of the electrical transducer regulatory device 104 for communications of oscillations to the skin of the user.
Initial data supports the use of a vibratory device for regulating stress and its physiological correlates. In an experiment with N=38 individuals of whom 9 were associates and 29 were community participants who were compensated for participation, vibratory stimulation at a main frequency of 100 Hz modulated by a modulation frequency of 0.1 Hz, delivered to the wrist, improved performance reliably (p< 05) and, to the chest, marginally (p<=.1) during a stressful (paced auditory serial attention) task above and beyond a no-stimulation condition for those whose performance was at least moderate (above 1 -standard deviation below the mean) during the no-stimulation condition. Vibration at this frequency also moderated changes in heart-rate variability (which is a proxy for parasympathetic tone), with statistically significant (p<.05) increases in heart rate variability delivered to the wrist in the full sample and delivered to the sternum in the compensated sample (p=.09 in the full sample). Vibration at this frequency delivered to the sternum also decreased self-reported stress in those whose stress was at least moderate (above 1 standard deviation below the mean) compared to the no stimulation condition (p<.05).
Physiological detection and calibration
The physiological detection suite involves using custom and commercial software and hardware to acquire physiological parameters and analyzing them in real time to detect the onset of individualized signatures of stress, fatigue, or other (e.g. , user specified) emotion or arousal states.
FIG 4 shows an example of implemented software for detection of physiological profiles associated with an emotion state and generation of reactive stimulation. FIG 4 depicts a user interface, illustrated based on a screen capture of the software, wherein the user has selected a threshold of three, as is indicated by the "THRESHOLD" indicator, and which is reflected by the dashed line in the bar graph of FIG 4. An exemplary stress level pattern is depicted at the top of FIG 4, and the bar indicator in the bar graph demonstrates that the threshold has not been reached. It is noted that FIG 4 further depicts the user-selectable option to have either a tactile output in the form of a tactile-vibration/electrical stimulation or an audible output in the form of a chime when the user is determined to be in a stressed state. In the event of such a chime or no output, a user can manually enter an input using the buttons to trigger the outputting of the therapeutic stimulation. Alternatively, the user can select "NONE", which is selected in FIG 4. The event of the detected state of the user in a being stress (or other user selected emotion/arousal) condition with "Vibration" selected, will automatically result in outputting of the associated calibrated therapeutic stimulation.
In one implementation, software for detection of physiological states takes in pulse plethysmograph and galvanic skin response (GSR) inputs, sampled at 1000Hz, from existing hardware (e.g., Bitalino, Arduino) implemented as generic serial streams. The pulse plethysmograph detects a heartbeat signal that is representative of the heartbeat of the user.
GSR data are preprocessed via spike removal and smoothing (4 second kernel) to yield a smooth running estimate of GSR which is associated with sympathetic nervous system reactivity and stress. Plethysmograph data are preprocessed via spike removal and peak detection to yield heartbeats which are converted to an inter-beat interval series. The inter-beat series includes a time duration between each successive beat in the detected heartbeat signal.
The inter-beat interval series is subjected to calculation of heart rate (# beats per second).
The inter-beat interval series for 30 seconds is subjected to continuous Morlet waveform transform to yield a running estimate of power in the high frequency heart rate variability (HF-HRV) band (0.18-0.4 Hz), which is associated with parasympathetic nervous system activity and emotion regulation capability, and which can be referred to as an emotional regulation parameter or value. It is noted that other spectra! analysis techniques such as Fourier transformation and the like can be employed without departing from the spirit of the disclosed and claimed concept.
One aspect of the algorithm for detection of physiological stress includes quantifying change or slope over a period of time, i.e., 100ms to 30 seconds, in physiological parameters to detect state onset.
The algorithm for detecting physiological stress is initially seeded for stress detection as reflecting increasing detected current physical parameters such as GSR or heart rate without a corresponding or subsequent change in HF-HRV, i.e.:
estimated-stress = βο + p-iAGSRs + β 2ΔΗ63ΓΪ R3t6s 3|AHF-HRV5
where the coefficients are initially β0= 0, βι=0.5, β2=0.5, β3=1 and GSR, HR, and HF- HRV are normalized based on their mean and variability during an initial resting calibration period of 30-seconds. Other detected current physical parameters could include a number of audio parameters that are representative of vocal stress, and other such parameters.
Another aspect of the algorithms includes a calibration operation using software that guides the user to experience resting, stressed, fatigued or other user-specified states, and which includes brief exposure to a stress induction known to provoke increases in sympathetic tone and decreases in parasympathetic tone (e.g., paced serial attention task), to yield an individually calibrated profile for these states (e.g., "stress profile"). For instance, a number of calibration physical parameters of the user such as heart rate signal, GSR signal, and other such parameters, may be detected and stored in the storage 52. The software that performs the guiding can be executed on the regulatory device or can be deployed on a smart phone or other computerized device remote from the regulatory device. Another aspect of the algorithms includes machine learning to derive
individualized best-fit profiles for what stress-onset, fatigue onset, or other user- determined states look like for the individual. In the implemented software, as an example, a machine learning algorithm such as a three-layer pattern recognition neural network with 8 input nodes, 4 hidden nodes, and 1 output node is used to estimate how GSR, Heart Rate, HF-HRV, and estimated change in each of these in the previous 5 seconds combine to predict based on the calibration task described in the preceding paragraph. Effectively this algorithm allows a quantized (sigmoid) ridge-regression estimation of parameters for main effects of each of these parameters, and their potential n-way interactions:
estimated-stress = βο + p-iAGSRs seconds + 2AHeart Rates seconds + 3|AHF-HRV5 seconds I + 4GSRs seconds + β sHeart Rates seconds + PeHF-HRVs seconds + zAGSRs seconds *ΔΗβ3ΓΪ Rates seconds"1" β8ΔGSR5 seconds * |AHF-HRVs seconds] ... NAGSRS seconds * ΔΗθ3ΓΪ Rates seconds * lAHF-HRVs seconds I * GSRs seconds Heart Rates seconds * HF-HRVs seconds
To derive beta weights for the preceding equation, stress values are set to zero during rest and one (1) during the target state, e.g., stress. Thus, "estimated-stress" represents the extent to which a current state is more like the stress vs the resting state. The same type of analysis can be performed for a fatigue or user-specified period. The various β coefficients that are derived through the use of the pattern recognition neural network form a part of the individually calibrated profile that can be used to detect the onset of a period of stress or fatigue. It is understood that additional elements can be added to the above equation in order to derive additional coefficients for use with calibration physical parameters and current physical parameters that are indicative of vocal stress in the user.
Another aspect of the algorithms includes real-time comparison of incoming physiological data in the form of current physical parameters of the user to the individualized best-fit profiles to determine when an individual is beginning to look stressed, fatigued, or a critical distance from a user defined state, so as to trigger the delivery of therapeutic stimulation. Stimulation is signaled whenever the stress index is outside 1.5 standard deviations from its mean, which refers to the aforementioned threshold of "3" in FIG 4. Stimulation is signaled at lower and higher stress levels if the threshold is set lower or higher, respectively, than "3".
FIG 6 shows that we can derive a classifier that detects the onset of stress during a stressful serial addition task. Vocal detection and calibration
FIG 5 shows an example of implemented software for detection of vocal stress. One aspect of the vocal stress detection algorithm is that speech is recorded in 5- second segments. These segments are processed to extract common vocal parameters such as speech rate, pitch, mean frequency, frequency of the first fundamental, variance of the first fundamental, etc. using publicly available code. The speech data from any 5- second segment is not saved after parameters are extracted, and thus no lasting voice recordings are made.
Another aspect is that a 4-layer pattern-network classifier was trained to recognize the emotion associated with short vocalizations (neutral, calm, happy, sad, fearful, angry, disgusted, surprised) using the "RAVDESS" speech corpus
(http://smai11aboratory.ofq/ravdess/desjCjnieatures/) preprocessed to be z-scores normalized by the mean of vocalizations and divided by the standard deviation. Outliers were Windsorized to the next good value outside the Tukey Hinges. The network had 15 inputs for vocal parameters, 2 hidden layers with 15 and 10 units respectively, and 8 outputs - one per classified emotion and was trained with a standard back-propagation algorithm. Classification was 30-80% accurate for specific valences depending on the valence.
Another aspect of the algorithm is that extracted speech parameters are normalized by subtracting the mean of a set of six five-second "neutral" calibration vocalizations and dividing by the standard deviation these vocalizations.
Another aspect of the vocal stress detection algorithm is that it begins with a calibration consisting of recording 30 seconds of silence in a specific room. The variance of incoming 5-second vocalizations are, at each iteration, compared to the variance of the "silence" recording. Audio waveforms with variability outside 2 standard deviations (SD) from the silence recording are considered to be vocalizations; otherwise they are considered silence and not categorized.
Another aspect of the vocal stress detection algorithm is that a second calibration records an individual person, who is the subject of measurement, speaking in a neutral tone for 30 seconds.
Another aspect of the algorithm is that when more than a user-selected number of the vocal parameters (the user can select from 2-8 parameters) are outside 2 SD from the mean of neutral vocalizations, and when the person is deemed, via classification based on the RAVDESS corpus classifier, to have a negative tone (fear, sadness, disgust), the software provides user-selected stimulation waveforms to the stimulation generator. This is depicted in the user interface capture from the software that is depicted in FIG 5 wherein the user has selected a threshold of four parameters, as is indicated by the "THRESHOLD" indicator, and which is reflected by the dashed line in the bar graph of FIG 5. An exemplary vocal wave pattern is depicted at the top of FIG 5, and the bar indicator in the bar graph demonstrates that the threshold has not been reached. It is noted that FIG 5 further depicts the user-selectable option to have either a tactile output in the form of a vibration or an audible output in the form of a chime when the user is determined to be in a stressed state. In the event of such an output, a user can manually enter an input using the buttons to trigger the outputting of the therapeutic stimulation. Alternatively, the user can select "NONE", which is selected in FIG 5. In the Vibration condition, and in the event of the detected state of the user being stress or another user-specified condition, this will automatically result in the outputting of the therapeutic stimulation.
Stimulation calibration
The stimulation calibration algorithm performs a customization operation that involves presenting individuals with a plurality of customization stimulations in the form of a range of stimulation parameters and allowing them to rate the emotionality and arousal associated with these types of stimulation. In response to each customization stimulation, the user inputs to the software a number of responses using a single selection on a grid. The number of responses are representative of how the user perceived the customization stimulation on an arousal scale between very calming and very arousing, and are further representative of how the user tolerated the customization stimulation on a valence scale between very negatively and very positively. To best tune stimulation to an individuals' preferences, the software selects stimulation patterns based on these ratings. The pattern which is rated as maximally positive and maximally calming (sqrt of the squared distance on each axis from neutral) is used as the calming stimulation pattern for that individual in the event of detecting that the individual is experiencing a stress condition. The pattern which is maximally arousing, regardless of its valence, is used as the arousing stimulation pattern for that individual in the event of detecting that the individual is experiencing a fatigue condition.
FIGS 7A, 7B, 7C, AND 7D show that there are reliable overall differences in emotion and arousal as a function of oscillation patterns for the vibrating transducer and that there are individual differences in which patterns are most calming and arousing for different individuals. Each data point in such figures is representative of how the user perceived the customization stimulation on an arousal scale between very calming and very arousing, and additionally how the user tolerated the customization stimulation on a valence scale between very negatively and very positively. State storage and use in "restoring" saved states
Physiological parameters in the form of baseline physical parameters associated with named target emotional states (e.g., "stress" or "positive affect calm") can be stored for later recall as targets (triggers stimulation that decreases distance to the state when it is determined that a number of current physical parameters are more than a
predetermined distance of those of the target emotional state) or alarms (triggers stimulation that increases distance from the state when it is determined that a number of current physical parameters are within a predetermined distance of those of the target emotional state).
Another aspect of the invention includes software that allows subjective and physiologically based storage of stimulation parameters that optimally yield approach or departure from target or alarm states.
Another aspect of the present invention includes software that allows users to specify potentially new or idiosyncratic target or alarm emotion states for storage in a library which includes associated physiological profiles and stimulation parameters.
Another aspect of the present invention is that physiological profiles can be used to gauge distance from normed and idiosyncratically named categories by the cosine of current physiological parameters with those for calibrated states, e.g., yielding a
"Closeness" value C for each parameter, e.g.,
Figure imgf000017_0001
GSRsession mean )*(GSR_ calibration state" GSR_caiibration session mean) and deriving the "Closeness" to a state as BGS *CGSR+BHRv*CHRv+Bvocai Pitch*Cvocai Pitch where associated B weights are derived via neural network classifiers as described herein before.
This algorithm provides distance from target states. Before calibration, a priori rules are used to specify output transduction to optimally restore a state via minimizing distance (e.g., Euclidean) of current data from template vectors as described herein before.
Another aspect of the present invention includes software that allows users to share emotion state names, associated physiological profiles, and stimulation parameters for approaching or avoiding them. Possible Practical Applications
A source for generating physiologically reactive oscillation patterns (e.g., smartphone) wherein the oscillation patterns are frequencies in the range of 20-300 Hz modulated by frequencies from 0.01-10 Hz.
The source generates oscillations and transmits them via Bluetooth. Software is used to calibrate and store what vibration patterns maximally yield specific emotional states, including those specified by a user, such as arousal, or positive-affect calm for a given individual, or that individual's state on a given day, to which they would like to return in the future.
This software can store what vibration patterns individuals are using and dynamically update its calibration to "learn" if users choose to use patterns not suggested by the previous calibration.
A Bluetooth receiver for oscillation patterns generated by the source.
A switch, software control, or physiological/vocal measurement device to determine when the oscillation patterns are delivered.
The software computes the magnitude and slope of physiological or vocal measures over a local window (0.5-30 seconds) to determine onsets of emotion state deviations from a neutral state (e.g., stress, fatigue).
The software compares incoming physiological measurements to an individually calibrated profile to determine likelihood of onset of an emotion state and the appropriate reaction.
The software has a calibration routine that requires the individual to attain relaxed/neutral, stressed (e.g., via stressful cognitive task), or fatigued states, and record data for profile derivation.
The software uses machine learning algorithms (e.g., neural networks) to derive individually calibrated emotion state (e.g., stress) indices from the calibration data used as a training set.
The software stores learned physiological patterns in a library that can be recalled in combination with associated stimulation patterns as described to allow "restoration" of "saved" states.
A battery to power the amplifier.
An amplifier that raises the received oscillation patterns to a non-ignorable level.
Transducers that provide one of vibratory and electrical stimulation.
A sleeve for the vibratory transducer that can be removed and washed.
The sleeve may allow the device to be attached to the individual, e.g., via a band or other means for securing the device to the body part without disrupting the transducer's functionality.
In the claims, any reference signs placed between parentheses shall not be construed as limiting the claim. The word "comprising" or "including" does not exclude the presence of elements or steps other than those listed in a claim. In a device claim enumerating several means, several of these means may be embodied by one and the same item of hardware. The word "a" or "an" preceding an element does not exclude the presence of a plurality of such elements. In any device claim enumerating several means, several of these means may be embodied by one and the same item of hardware. The mere fact that certain elements are recited in mutually different dependent claims does not indicate that these elements cannot be used in combination. Although the invention has been described in detail for the purpose of illustration based on what is currently considered to be the most practical and preferred embodiments, it is to be understood that such detail is solely for that purpose and that the invention is not limited to the disclosed embodiments, but, on the contrary, is intended to cover modifications and equivalent arrangements that are within the spirit and scope of the appended claims. For example, it is to be understood that the present invention contemplates that, to the extent possible, one or more features of any embodiment can be combined with one or more features of any other embodiment.

Claims

CLAIMS What is claimed is:
1. A method of employing a regulatory device to provide stimulation therapy to a user, comprising:
detecting on the regulatory device a predetermined input; and responsive to the predetermined input, generating with the regulatory device a therapeutic stimulation in the form of at least one of vibrational output applied to the user's body and an electrical output applied as a voltage to the user's skin, the therapeutic stimulation comprising a combination of oscillations that include at least a main oscillation at a first frequency in the range of about 20-300 Hz and a modulation oscillation at a second frequency different than the first frequency in the range of about 0.05-10 Hz that together form a beat output.
2. The method of Claim 1 wherein the therapeutic stimulation comprises an electrical output in the form of a pulse-width-modulation waveform.
3. The method of Claim 1 wherein the predetermined input is one of a manual input by the user that is received on the regulatory device and a detection of a predetermined condition of the user.
4. The method of Claim 1 wherein the predetermined input is a detection of a predetermined condition of the user, and further comprising:
detecting with the regulatory device a number of current physical parameters of the user; and
making a determination based at least in part upon the number of current physical parameters that the predetermined condition exists in the user.
5. The method of Claim 4, further comprising:
detecting with the regulatory device as at least a part of the number of current physical parameters a heartbeat signal that is representative of a heartbeat of the user;
determining a number of values of the user that are representative of at least one of sympathetic and parasympathetic nervous system activity of the user and that is based at least in part upon the heartbeat signal; and
determining the existence of the predetermined condition in the user based at least in part upon the number of values derived from the heartbeat signal.
6. The method of Claim 5, further comprising: detecting with the regulatory device as at least a part of the number of current physical parameters a Galvanic Skin Response (GSR) signal that is
representative of a galvanic skin response in the skin of the user; and
determining the existence of the predetermined condition in the user when a change in the GSR signal is detected in conjunction with values derived from the heartbeat signal.
7. The method of Claim 6, further comprising:
detecting with the regulatory device as at least a part of the number of current physical parameters one or more audio parameters that are representative of vocal tone in the user; and
determining the existence of the predetermined condition in the user when a change in vocal parameters is detected in conjunction with changes in the GSR signal and values derived from the heartbeat signal.
8. The method of Claim 4, further comprising:
detecting with the regulatory device as at least a part of the number of current physical parameters a vocal signal that is representative of a vocal output of the user;
determining a number of values of the user that are representative of at least one of sympathetic and parasympathetic nervous system activity of the user and that is based at least in part upon the vocal signal; and
determining the existence of the predetermined condition in the user based at least in part upon the number of values derived from the vocal signal.
9. The method of Claim 1 , further comprising performing a calibration operation by:
guiding the user through a plurality of states of the user including at least two of a resting state, a stressed state, and a fatigued state;
detecting with the regulatory device a number of calibration physical parameters of the user in each state of the plurality of states; and
deriving an individually calibrated profile for the user based at least in part upon at least some of the calibration physical parameters of the number of calibration physical parameters.
10. The method of Claim 9 wherein the deriving of the individually calibrated profile comprises subjecting at least some of the calibration physical parameters to a machine learning algorithm to derive a number of coefficients that are a part of the individually calibrated profile.
1 1. The method of Claim 9, further comprising: detecting with the regulatory device a number of current physical parameters of the user;
making a determination based at least in part upon the number of current physical parameters and the individually calibrated profile that a predetermined condition exists in the user; and
responsive to the determination, performing at least one of: employing the determination as the predetermined input, and outputting at least one of a visible indication, an audible indication, and a tactile indication that the predetermined condition exists in the user, and awaiting a manual input from the user before initiating the generating.
12. The method of Claim 9, further comprising performing the guiding of the user through the plurality of states by employing an application deployed on at least one of the regulatory device and a separate computerized device.
13. The method of Claim 1 , further comprising performing a customization operation by:
outputting with the regulatory device a plurality of customization stimulations, each customization stimulation being in the form of at least one of a vibrational output applied to the user's body and an electrical output applied as a voltage to the user's skin, the customization stimulation comprising a combination of oscillations that include at least a main oscillation at a first frequency in the range of about 20-300 Hz and a modulation oscillation at a second frequency different than the first frequency in the range of about 0.01-10 Hz apart that together form a beat output;
for each customization stimulation of the plurality of customization stimulations, receiving from the user an input that is representative of how the user perceived the customization stimulation on an arousal scale between very calming and very arousing, and receiving from the user another input that is representative of how the user tolerated the customization stimulation on a valence scale between very negatively and very positively.
14. The method of Claim 13, further comprising:
identifying a particular customization stimulation from among the plurality of customization stimulations as having the greatest combination of being closest to very calming on the arousal scale and very positively on the valence scale; and
outputting the particular customization stimulation as the therapeutic stimulation.
15. The method of Claim 14 wherein the predetermined input is a detection of a stress condition of the user, and further comprising: detecting with the regulatory device a number of current physical parameters of the user; and
making a determination based at least in part upon the number of current physical parameters that the stress condition exists in the user.
16. The method of Claim 13, further comprising:
identifying a specific customization stimulation from among the plurality of customization stimulations as being closest to very arousing on the arousal scale; and outputting the specific customization stimulation as the therapeutic stimulation.
17. The method of Claim 16 wherein the predetermined input is a detection of a fatigue condition of the user, and further comprising:
detecting with the regulatory device a number of current physical parameters of the user; and
making a determination based at least in part upon the number of current physical parameters that the fatigue condition exists in the user.
18. The method of Claim 1 , further comprising:
detecting with the regulatory device a number of baseline physical parameters of the user;
recording the number of baseline physical parameters as a target emotional state; and
detecting with the regulatory device a number of current physical parameters of the user;
making a determination that the number of current physical parameters exceed a predetermined distance from the target emotional state; and
employing the determination as the predetermined input.
19. The method of Claim 1 , further comprising:
detecting with the regulatory device a number of baseline physical parameters of the user;
recording the number of baseline physical parameters as a target emotional state; and
detecting with the regulatory device a number of current physical parameters of the user;
making a determination that the number of current physical parameters is within a predetermined distance of the target emotional state; and
employing the determination as the predetermined input.
20. A regulatory device structured to provide stimulation therapy to a user, the regulatory device comprising a processor apparatus having a processor and a storage, the storage having stored therein one or more routines which, when executed on the processor, cause the therapeutic apparatus to perform operations comprising:
detecting on the regulatory device a predetermined input; and responsive to the predetermined input, generating with the regulatory device a therapeutic stimulation in the form of at least one of vibrational output applied to the user's body and an electrical output applied as a voltage to the user's skin, the therapeutic stimulation comprising a combination of oscillations that include at least a main oscillation at a first frequency and a modulation oscillation at a second frequency different than the first frequency that together form a beat output.
21. A non-transitory machine readable storage medium having stored therein instructions which, when executed on a processor of a regulatory device, cause the regulatory device to perform operations comprising:
detecting on the regulatory device a predetermined input; and responsive to the predetermined input, generating with the regulatory device a therapeutic stimulation in the form of at least one of vibrational output applied to the user's body and an electrical output applied as a voltage to the user's skin, the therapeutic stimulation comprising a combination of oscillations that include at least a main oscillation at a first frequency and a modulation oscillation at a second frequency different than the first frequency that together form a beat output.
PCT/US2017/025702 2016-04-01 2017-04-03 Regulatory device and associated method WO2017173436A1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AU2017240259A AU2017240259A1 (en) 2016-04-01 2017-04-03 Regulatory device and associated method
US16/088,608 US11660442B2 (en) 2016-04-01 2017-04-03 Regulatory device and associated method
CA3019351A CA3019351C (en) 2016-04-01 2017-04-03 Regulatory device and associated method
EP17776899.1A EP3436135B1 (en) 2016-04-01 2017-04-03 Regulatory device and associated method
JP2019502540A JP6952762B2 (en) 2016-04-01 2017-04-03 Adjustment device and storage medium
KR1020187031837A KR102452785B1 (en) 2016-04-01 2017-04-03 Regulators and related methods
CN201780029173.8A CN109152917B (en) 2016-04-01 2017-04-03 Supervisory apparatus and associated methods
IL262065A IL262065B2 (en) 2016-04-01 2017-04-03 Regulatory device and associated method
US16/596,351 US20200061377A1 (en) 2016-04-01 2019-10-08 Regulatory Device and Associated Method For Treating Depression
AU2022221421A AU2022221421A1 (en) 2016-04-01 2022-08-23 Regulatory device and associated method

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662316695P 2016-04-01 2016-04-01
US62/316,695 2016-04-01

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US16/088,608 A-371-Of-International US11660442B2 (en) 2016-04-01 2017-04-03 Regulatory device and associated method
US16/596,351 Continuation-In-Part US20200061377A1 (en) 2016-04-01 2019-10-08 Regulatory Device and Associated Method For Treating Depression

Publications (1)

Publication Number Publication Date
WO2017173436A1 true WO2017173436A1 (en) 2017-10-05

Family

ID=59966515

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2017/025702 WO2017173436A1 (en) 2016-04-01 2017-04-03 Regulatory device and associated method

Country Status (9)

Country Link
US (1) US11660442B2 (en)
EP (1) EP3436135B1 (en)
JP (1) JP6952762B2 (en)
KR (1) KR102452785B1 (en)
CN (1) CN109152917B (en)
AU (2) AU2017240259A1 (en)
CA (1) CA3019351C (en)
IL (1) IL262065B2 (en)
WO (1) WO2017173436A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020082906A (en) * 2018-11-20 2020-06-04 アイシン精機株式会社 Wakefulness support device, wakefulness support method and wakefulness support program
US20200215297A1 (en) * 2019-01-04 2020-07-09 Apollo Neuroscience, Inc. Systems and methods of mitigating negative effects of therapies with transcutaneous vibration
US10786666B2 (en) 2018-01-30 2020-09-29 Apex Neuro Holdings Inc. Devices and methods for delivering mechanical stimulation to nerve, mechanoreceptor, and cell targets
US10959674B2 (en) 2017-10-23 2021-03-30 Datafeel Inc. Communication devices, methods, and systems
CN115381413A (en) * 2021-10-21 2022-11-25 中国科学院心理研究所 Self-adaptive bimodal emotion adjusting method and system
US11934583B2 (en) 2020-10-30 2024-03-19 Datafeel Inc. Wearable data communication apparatus, kits, methods, and systems
US11944757B2 (en) 2020-01-08 2024-04-02 New Heights Energy, LLC Therapy devices for providing pressure therapy and breathing therapy to a user and/or for measuring physiological parameters of the user
US11969557B1 (en) 2024-01-04 2024-04-30 New Heights Energy, LLC Wearable devices for providing pressure therapy to a user

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10827942B2 (en) * 2018-01-03 2020-11-10 Intel Corporation Detecting fatigue based on electroencephalogram (EEG) data
JP7141680B2 (en) * 2018-01-29 2022-09-26 株式会社Agama-X Information processing device, information processing system and program
US11006875B2 (en) * 2018-03-30 2021-05-18 Intel Corporation Technologies for emotion prediction based on breathing patterns
JP6963668B1 (en) * 2020-12-03 2021-11-10 ポーラ化成工業株式会社 Solution provision system
WO2022118955A1 (en) * 2020-12-03 2022-06-09 ポーラ化成工業株式会社 Solution providing system
JP6963669B1 (en) * 2020-12-03 2021-11-10 ポーラ化成工業株式会社 Solution providing system and mobile terminal
US20230008214A1 (en) * 2021-07-11 2023-01-12 Michael Northen Vibration producing device with sleep cycle function and transducer

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030001008A1 (en) * 1999-12-15 2003-01-02 Francois Berrube Electronic label system for displaying prices in a sale outlet
US20070219470A1 (en) * 2006-03-08 2007-09-20 Talish Roger J System and method for providing therapeutic treatment using a combination of ultrasound, electro-stimulation and vibrational stimulation
US20120149973A1 (en) * 2004-12-22 2012-06-14 Holloway G Blake Systems and Methods for Balancing and Maintaining the Health of the Human Autonomic Nervous System
US20140148872A1 (en) * 2012-11-26 2014-05-29 Isy Goldwasser Wearable transdermal electrical stimulation devices and methods of using them
US20140163439A1 (en) * 2003-09-04 2014-06-12 Parallel Biotechnologies LLC Musical vibration system localized proximate a target artery

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10055686A1 (en) * 2000-11-03 2002-05-08 Biotronik Mess & Therapieg Device for influencing cell proliferation mechanisms in vessels of the human or animal body
US20030083599A1 (en) * 2001-11-01 2003-05-01 Zeev Kitov Acoustic band vibration massage for muscle relaxation: method and device
US8788044B2 (en) * 2005-01-21 2014-07-22 Michael Sasha John Systems and methods for tissue stimulation in medical treatment
CN101096841A (en) 2006-06-27 2008-01-02 克斯查理 Protection system for preventing cable and column lever from destructing by dynamic impacting and method thereof
WO2009018518A1 (en) * 2007-08-02 2009-02-05 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Methods and systems for achieving a physiological response by pudendal nerve stimulation and bockade
US9132333B2 (en) * 2008-06-06 2015-09-15 Koninklijke Philips N.V. Method and system for maintaining a state in a subject
US8004391B2 (en) 2008-11-19 2011-08-23 Immersion Corporation Method and apparatus for generating mood-based haptic feedback
US20100152620A1 (en) 2008-12-12 2010-06-17 Immersion Corporation Method and Apparatus for Providing A Haptic Monitoring System Using Multiple Sensors
TWI636784B (en) 2011-04-05 2018-10-01 大塚製藥股份有限公司 PHARMACEUTICAL COMPOSITION AND KIT COMPRISING 7-[4-(4-BENZO[b]THIOPHEN-4-YL-PIPERAZIN-1-YL)BUTOXY]-1H-QUINOLIN-2-ONE AND USE THEREOF
US10632040B2 (en) 2012-02-29 2020-04-28 Frederick Muench Systems, devices, components and methods for triggering or inducing resonance or high amplitude oscillations in a cardiovascular system of a patient
US10814131B2 (en) 2012-11-26 2020-10-27 Thync Global, Inc. Apparatuses and methods for neuromodulation
US10504339B2 (en) 2013-02-21 2019-12-10 Immersion Corporation Mobile device with instinctive alerts
US9202352B2 (en) 2013-03-11 2015-12-01 Immersion Corporation Automatic haptic effect adjustment system
US20140276270A1 (en) * 2013-03-13 2014-09-18 Passy-Muir, Inc. Systems and methods for stimulating swallowing
US20150335288A1 (en) * 2013-06-06 2015-11-26 Tricord Holdings, Llc Modular physiologic monitoring systems, kits, and methods
KR20160105321A (en) 2015-02-27 2016-09-06 임머숀 코퍼레이션 Generating actions based on a user's mood
US20170296429A1 (en) 2016-04-18 2017-10-19 VMAS Solutions LLC System and method for reducing chronic and acute stress
US11033709B2 (en) 2018-11-14 2021-06-15 Vmas Solutions Inc. System and method for reducing stress
AU2019419450A1 (en) 2019-01-04 2021-07-22 Apollo Neuroscience, Inc. Systems and methods of wave generation for transcutaneous vibration

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030001008A1 (en) * 1999-12-15 2003-01-02 Francois Berrube Electronic label system for displaying prices in a sale outlet
US20140163439A1 (en) * 2003-09-04 2014-06-12 Parallel Biotechnologies LLC Musical vibration system localized proximate a target artery
US20120149973A1 (en) * 2004-12-22 2012-06-14 Holloway G Blake Systems and Methods for Balancing and Maintaining the Health of the Human Autonomic Nervous System
US20070219470A1 (en) * 2006-03-08 2007-09-20 Talish Roger J System and method for providing therapeutic treatment using a combination of ultrasound, electro-stimulation and vibrational stimulation
US20140148872A1 (en) * 2012-11-26 2014-05-29 Isy Goldwasser Wearable transdermal electrical stimulation devices and methods of using them

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11589816B2 (en) 2017-10-23 2023-02-28 Datafeel Inc. Communication devices, methods, and systems
US11931174B1 (en) 2017-10-23 2024-03-19 Datafeel Inc. Communication devices, methods, and systems
US10959674B2 (en) 2017-10-23 2021-03-30 Datafeel Inc. Communication devices, methods, and systems
US11864914B2 (en) 2017-10-23 2024-01-09 Datafeel Inc. Communication devices, methods, and systems
US11484263B2 (en) 2017-10-23 2022-11-01 Datafeel Inc. Communication devices, methods, and systems
US11864913B2 (en) 2017-10-23 2024-01-09 Datafeel Inc. Communication devices, methods, and systems
US11684313B2 (en) 2017-10-23 2023-06-27 Datafeel Inc. Communication devices, methods, and systems
US10786666B2 (en) 2018-01-30 2020-09-29 Apex Neuro Holdings Inc. Devices and methods for delivering mechanical stimulation to nerve, mechanoreceptor, and cell targets
US11504521B2 (en) 2018-01-30 2022-11-22 Apex Neuro Holdings, Inc. Devices and methods for delivering mechanical stimulation to nerve, mechanoreceptor, and cell targets
JP2020082906A (en) * 2018-11-20 2020-06-04 アイシン精機株式会社 Wakefulness support device, wakefulness support method and wakefulness support program
JP7081456B2 (en) 2018-11-20 2022-06-07 株式会社アイシン Awakening support device, awakening support method, and awakening support program
US11260198B2 (en) 2019-01-04 2022-03-01 Apollo Neuroscience, Inc. Systems and methods of wave generation for transcutaneous vibration
US11534571B2 (en) 2019-01-04 2022-12-27 Apollo Neuroscience, Inc. Systems and methods of facilitating sleep state entry with transcutaneous vibration
US10974020B2 (en) 2019-01-04 2021-04-13 Apollo Neuroscience, Inc. Systems and methods of mitigating negative effects of therapies with transcutaneous vibration
US11872351B2 (en) 2019-01-04 2024-01-16 Apollo Neuroscience, Inc. Systems and methods of multi-segment transcutaneous vibratory output
US20200215297A1 (en) * 2019-01-04 2020-07-09 Apollo Neuroscience, Inc. Systems and methods of mitigating negative effects of therapies with transcutaneous vibration
US11944757B2 (en) 2020-01-08 2024-04-02 New Heights Energy, LLC Therapy devices for providing pressure therapy and breathing therapy to a user and/or for measuring physiological parameters of the user
US11934583B2 (en) 2020-10-30 2024-03-19 Datafeel Inc. Wearable data communication apparatus, kits, methods, and systems
CN115381413B (en) * 2021-10-21 2023-10-24 中国科学院心理研究所 Self-adaptive bimodal emotion adjustment method and system
CN115381413A (en) * 2021-10-21 2022-11-25 中国科学院心理研究所 Self-adaptive bimodal emotion adjusting method and system
US11969557B1 (en) 2024-01-04 2024-04-30 New Heights Energy, LLC Wearable devices for providing pressure therapy to a user

Also Published As

Publication number Publication date
KR102452785B1 (en) 2022-10-11
IL262065B2 (en) 2023-12-01
US11660442B2 (en) 2023-05-30
JP6952762B2 (en) 2021-10-20
CN109152917A (en) 2019-01-04
IL262065A (en) 2018-11-29
AU2017240259A1 (en) 2018-10-18
EP3436135A4 (en) 2019-10-02
CA3019351A1 (en) 2017-10-05
JP2019518572A (en) 2019-07-04
EP3436135A1 (en) 2019-02-06
EP3436135B1 (en) 2022-04-27
US20190076643A1 (en) 2019-03-14
KR20180132109A (en) 2018-12-11
CN109152917B (en) 2022-08-05
AU2022221421A1 (en) 2022-09-22
IL262065B1 (en) 2023-08-01
CA3019351C (en) 2023-09-12

Similar Documents

Publication Publication Date Title
US11660442B2 (en) Regulatory device and associated method
EP3756194B1 (en) System and method for delivering sensory stimulation to a user based on a sleep architecture model
JP5619728B2 (en) System for determining physiological state
US10939866B2 (en) System and method for determining sleep onset latency
CN107466241B (en) Providing sensory stimulation based on slow wave cycles
JP2016538009A (en) System and method for determining the timing of sensory stimulation during sleep
US20200061377A1 (en) Regulatory Device and Associated Method For Treating Depression
US20210205574A1 (en) Systems and methods for delivering sensory stimulation to facilitate sleep onset
Delmastro et al. Physiological impact of vibro-acoustic therapy on stress and emotions through wearable sensors
Costantini et al. Towards the enhancement of body standing balance recovery by means of a wireless audio-biofeedback system
Ramírez et al. Assessment of emotional states through physiological signals and its application in music therapy for disabled people
CN111372639B (en) System for delivering sensory stimuli to a user to enhance cognitive domains in the user
US11266807B2 (en) System and method for determining whether a subject is likely to be disturbed by therapy levels of stimulation during sleep sessions
US20200197656A1 (en) System and method for enhancing rem sleep with sensory stimulation
Kleinberger Vocal Musical Expression with a Tactile Resonating Device and its Psychophysiological Effects.
EP4082019A1 (en) Systems and methods for delivering sensory stimulation to facilitate recovery

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 3019351

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2019502540

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2017240259

Country of ref document: AU

Date of ref document: 20170403

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 20187031837

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2017776899

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17776899

Country of ref document: EP

Kind code of ref document: A1